BACKGROUND AND PURPOSE:
We report our initial experience with ihtObtura, a novel nonadhesive liquid embolic agent (LEA) with progressive postembolization loss of radiopacity for curative embolization of brain AVMs (bAVMs).
MATERIALS AND METHODS:
A post hoc analysis of the CLARIDAD trial, a single-center, first-in-human study, was performed. Collected data on consecutive patients with bAVMs treated with ihtObtura (between November 2021 and September 2022) were analyzed. Patient demographics, AVM…